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Abstract: 
Presented dissertation thesis is focused on novel preparation of biodegradable 
polyurethanes (PUs) and their modification by biologically active cellulose nanocrystals. 
Literary review deals with current state of bioresorbable PUs used in tissue engineering. 
Examples of prepared PU elastomers, scaffolds and injectable PUs, together with 
biodegradation pathways to non-toxic products are summarized. The last part of the literary 
review is targeting on nanocellulose, which has gained much attention for the use as 
biomedical material due to its remarkable physical (high specific surface area, mechanical 
reinforcement) and biological (biocompatibility, biodegradability and low toxicity) properties. 
Experimental part presents characterization of biodegradable amphiphilic polyurethane 
films (bio-PUs) synthesized by solvent free polyaddition reaction of hydrophilic 
poly(ethylene glycol) (PEG) and hydrophobic poly(-caprolactone) (PCL) as macrodiols with 
hexamethylene diisocyanate. Prepared bio-PUs were characterized on one hand by means of 
different PEG/PCL ratio and on the other hand by changing the isocyanate ratio between 
NCO/OH groups. Abrupt enhancement of mechanical properties was observed when 
PEG/PCL weight ratio was equal to or less than 20/80 and was ascribed to the PCL ability to 
form crystalline domains. The increasing amount of PEG promoted the ability of bio-PUs to 
absorb water and enhance the rate of hydrolytic degradation. Whereas, reducing the ability of 
bio-PUs to absorb water and prolonged time of hydrolytic degradation was achieved with 
increasing the crosslink density by enhancing the isocyanate ratio. The last part deals with 
novel solvent free preparation of nanocomposite utilizing bio-PU as a matrix and cellulose 
nanocrystals either neat or surface grafted by PEG. Structural analysis demonstrated that the 
presence of rod-like nanoparticles causes the immobilization of the PU chains in matrix 
resulting in increased stiffness and rigidity of bio-PU/cellulose nanocomposite. 
By adjusting the PEG/PCL ratio, the amount of isocyanate or the presence of nanofiller, 
the novel bio-PU material with desirable mechanical (toughness, flexibility) and physical 
(swelling, degradation) properties can be obtained. Prepared solvent free bio-PUs may 
advantageously be used in regenerative medicine for soft tissue regeneration (e.g. as vascular 
grafts). 
 
Keywords: 
Polyurethane, poly(ethylene glycol), poly(-caprolactone), nanocellulose, nanocomposite, 
tissue engineering 
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Abstrakt: 
Předkládaná dizertační práce se zabývá novým způsobem přípravy biodegradabilních 
polyuretanů (PU) a jejich modifikací biologicky aktivními celulózovými nanokrystaly. 
Literární rešerše se zaměřuje na bioresorbovatelné PU v tkáňovém inženýrství. Shrnuje 
příklady těchto PU elastomerů, skafoldů (nosičů buněk) i injektovatelných PU společně se 
způsoby biodegradace na netoxické produkty. Poslední část je zaměřena na nanocelulózu, 
která si získala pozornost díky svým pozoruhodným fyzikálním (velký specifický povrch, 
mechanické vlastnosti) a biologickým (biokompatibilita, biodegradabilita a nízký toxicita) 
vlastnostem jako materiál pro biomedicínu. 
V experimentální části byly charakterizovány amfifilní biodegradovatelné polyuretanové 
filmy (bio-PU) syntetizované bez použití rozpouštědla polyadiční reakcí z hydrofilního 
poly(ethylenglykolu) (PEG) a hydrofobního poly(-kaprolaktonu) (PCL) jako makrodiolů 
společně s hexamethylen diizokyanátem. Připravené bio-PU filmy byly charakterizovány pro 
různé poměry jak mezi PEG/PCL, tak i mezi NCO/OH reagujícími skupinami (izokyanátový 
poměr). Bio-PU filmy projevily markantní nárůst mechanických vlastností při hmotnostním 
poměru PEG/PCL rovnému nebo menšímu než 20/80 díky vzniku krystalických domén PCL. 
Přítomnost PEGu zvyšovala schopnost bio-PU filmu absorbovat vodu i urychlila jeho 
hydrolytickou degradaci. Oproti tomu nižší absorpční schopnost a delší čas hydrolytické 
degradace materiálu způsobil vyšší  izokyanátový poměr, a tedy i vyšší síťová hustota. Třetí 
část práce se zabývá přípravou polyuretanových nanokompozitů unikátní metodou bez použití 
rozpouštědla za využití bio-PU matrice a celulózových nanokrystalů buď nemodifikovaných, 
nebo povrchově roubovaných PEGem. Strukturní analýza prokázala, že přítomnost 
tyčinkovitých nanočástic způsobuje imobilizaci polymerních segmentů, v důsledku čehož se 
zvýšila tuhost a křehkost materiálu. 
Nastavením vhodného poměru mezi PEG/PCL, množstvím izokyanátu, či přídavkem 
modifikovaného nanoplniva může být bio-PU materiál „ušit na míru“ s vhodnými 
mechanickými (houževnatost, tažnost) a fyzikálními (botnání, degradace) vlastnostmi. Díky 
přípravě bez použití rozpouštědla by mohly být připravené materiály využity v regenerativní 
medicíně jako např. cévní štěpy. 
 
Klíčová slova: 
polyuretan, polyethylenglykol, poly(-kaprolakton), nanocelulóza, nanokompozit, tkáňové 
inženýrství 
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1. INTRODUCTION 
Polyurethanes (PUs) form diverse class of elastomers covering broad range of chemical 
and physical properties. In addition to industrial applications, their structure can also be 
designed to form bioresorbable materials for use in human medicine [1–3]. Important features 
of PUs for the use in tissue engineering are tissue-specific biocompatibility, biodegradability, 
mechanical flexibility and moderate blood compatibility [4]. PUs have been available in 
medicine since the 1960s as bio-inert, hydrolytically stable materials (e.g. ventricle assist 
devices or heart valves [5]). Later on, bioresorbable PUs were introduced for various tissue 
constructs such as nerve conduits [6], vascular grafts [7], cartilage [8], cancellous bone graft 
substitutes [9] or as grafts for small diameter vascular replacement [10]. 
Moreover, bioresorbable PUs can be tailored to possess a broad range of mechanical 
properties by selections and content of soft and hard segments. Soft segments are commonly 
oligomeric macrodiols represented by linear polyesters such as poly(-caprolactone), 
poly(lactic acid) and poly(glycolic acid) or polyethers like poly(ethylene glycol) and 
poly(propylene glycol) having a low glass transition temperature (lower than 25 °C). The hard 
segments are provided by the combination of the chain extender and the diisocyanate 
component. The nature of hydrogen bonding in the hard segment causes a mutual attraction 
leading to a formation of hard and soft segment domains [11]. To eliminate the concern of 
aromatic amine by-products, the utilization of aliphatic diisocyanates (as alternatives to 
aromatic ones) provide a route to synthetize biodegradable polyurethanes yielding non-toxic 
degradation products [3]. 
Generally, current bioresorbable PUs are prepared in dimethyl sulfoxide or 
dimethylformamide (DMF) solvent followed by casting into a mold. This overcomes the 
problem with hydrophilic PEG component in PU, which is grabbing easily the water from air 
moisture within polymerization. The water reacts fast with isocyanate resulting in bubbles of 
carbon dioxide. The same strategy is commonly used for preparation of PU nanocomposites 
with cellulose nanocrystals (CNC). PU matrix is dissolved in DMF and CNC are dispersed in 
similar solvent. Mixing of those low viscous dispersions is enabling preparation of material 
with fine dispersion of nanoparticles. However, avoiding the use of organic solvent is 
favorable parameter in the material processing with the potential use in medicine. Therefore, 
preparation of either PU itself or PU-CNC nanocomposite in bulk is challenging. 
The aim of the work was to develop solvent free procedure eliminating organic solvents 
routinely used in PU synthesis. Polymerization conditions yielding compact biodegradable 
films were optimized. The experimental system was based on bioresorbable macrodiols from 
PEG and PCL and aliphatic 1,6-diisocyanato hexane (HDI), which is claimed as a non-toxic 
amine producer during polyurethane degradation [3]. For preparation of nanocomposites was 
chosen PU made of only PEG and HDI due to its amorphous nature. Effect of nanofiller on 
the matrix is then not shielded by the effects associated with crystallization. 
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 A range of bioresorbable PU systems with similar molecular structure [12-17] or 
nanocomposites made of PU and CNC [18, 19], has already been described in literature. Thus, 
the approach employed in this work to synthesize thermally crosslinked bio-PUs and PU-
CNC nanocomposites without the use of organic solvent is novel and original. 
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2. THEORETICAL PART 
2.1. Chemical structure of polyurethanes 
Polyurethanes (PU)s are a group of polymers prepared according to the diisocyanate-
polyaddition principle. The name polyurethane is derived from ethylcarbamate, known as 
urethane. The reaction of polyisocyanate with polyol leads to the formation of urethane bond, 
as illustrated in Figure 1. 
 
OCN R NCO +n
polyaddition
C NH R NH C O
O
CH2 O  
O
 
diisocyanate
n
n
OH O OH
or polyether
polyol
polyester
urethane bond
or polyether
polyester
 
 
Figure 1: General formation of polyurethane. 
Compared with other functional groups like ether-, ester-, and also urea-groups, the 
urethane groups represent often only a minority of the total composition (e.g. 4–6 % in 
flexible foams) [20]. Therefore, the properties are not significantly affected by the urethane 
groups. Most polyurethanes are composed of at least three components – long chain polyol, 
diisocyanate and chain extender. 
PU elastomers are characterized by a segment structure (alternating block copolymers) of 
the primary chain as showed in Figure 2. The secondary and tertiary structure and 
consequently, the morphology of these polyurethanes depend on the chemical composition 
and on the length of the segments (blocks). PU elastomers can be microphase separated to 
form hard and soft domains due to differences in polarity between the hard (polar) and soft 
(nonpolar) segments [11]. The soft segments typically have a glass transition temperature 
lower than 0 °C and are therefore rubbery at the room temperature. 
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Figure 2: Modelled primary structure of segmented polyurethane [20]. 
PUs can be either physically or chemically cross-linked by using the components with 
more than two functional groups, e.g., triisocyanate or a multihydroxyl polyol [21].  
Hydrogen bonding (Figure 3) between urethane and urea groups in the hard segments of 
adjacent polymer chains induces the formation of ordered hard domains, which function as 
physical crosslinks that resist flow when stress is applied to the material. To process the 
polymer, the physical crosslinks are broken by heating the material above the hard segment 
melting transition or by dissolving the material in an aprotic solvent, such as 
dimethylformamide (DMF). 
 
 
Figure 3: Hydrogen bonding between the chains of a polyurethane based on 1,6 – hexane 
diisocyanate and 1,4 – butane diol depicted according to [20]. 
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2.2. Bioresorbable polyurethanes 
It is important to distinguish between biodegradable and bioresorbable materials. 
Biodegradability means that the material degrades and moves away from the site of its action 
in vivo, but is not necessarily removed from the body. Bioresorbability then means total 
elimination of the initial foreign material and degradation of all low molecular weight 
compounds with no residual side effects [21]. 
Important features of PUs for tissue engineering are tissue-specific biocompatibility, 
biodegradability, mechanical flexibility and moderate blood compatibility. PUs were initially 
used in medicine as biostable materials. Various implantation sites for biostable PUs occurred 
in areas such as cardiovascular system (artificial heart [24], vascular grafts [25, 26] and stents 
[3, 27, 28]), the middle ear (artificial tympanic membrane [29]), the eye (artificial intraocular 
lenses [30]), the digestive tract (stent-like extensions for the oesophagus [31] or the 
replacement of biliary ducts [32]).  
Applications of bioresorbable polyurethanes appeared later on. As scaffolds they have 
already been used for various tissue constructs such as nerve conduits [6], vascular grafts [7], 
cartilage [8] or cancellous bone graft substitutes [9]. The usage of polyurethanes in medicine 
divided by standards of United States Food and Drug Administration (U.S. FDA) is 
summarized in Table 1. 
 
Table 1: Applications of polyurethanes in tissue engineering divided by U.S. FDA standards 
[11]. 
U.S. FDA class I or II: U.S. FDA class III: 
• Catheters, drains, medical tubing 
• Blood bags 
• Transdermal drug delivery patches 
• Surgical drapes and gowns 
• Transient cardiovascular devices 
• Intra-aortic balloon pumps 
• Temporary left ventricular assist devices 
and biventricular assist devices 
 
• Interim cardiovascular devices 
• Ventricular assist devices 
• Total artificial hearts used as temporary 
measure prior to organ transplantation 
(generally intended for less than a month) 
• Permanent cardiovascular devices 
(e.g. totally implantable ventricles, 
artificial hearts, pacemakers and leads, 
artificial heart valves) 
• Blood conduits and access devices 
• Wound dressings and barrier scaffolds 
• Contraceptives 
 
Note: Device FDA classification depends on the intended use of the device and also on the indications for 
use. In addition, classification is risk based. This means the risk the device poses to the patient and/or the user is 
a major factor in the class it is assigned. Class I includes devices with the lowest risk and Class III includes those 
with the greatest risk [33]. 
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2.3. Feedstocks for synthesis of bioresorbable polyurethanes 
The stability of PUs in the body depends on a number of factors including structure and 
composition. The synthesis of PUs requires at least two components, the first one is isocyanate 
and the second one is a bi- or multi-functional polyol.  
The direct reaction of diisocyanate with a long-chain diol usually yields a soft polymer 
with low mechanical strength. This property is usually changed by the addition of a chain 
extender, which is low molecular weight diol or diamine. Diamine chain extenders yield 
poly(urethane urea)s, which have higher hard segment melting temperatures and therefore 
harder mechanical properties compared to PUs obtained from diol chain extenders [34]. The 
properties of the final PU are primarily dependent on the chemical nature of mentioned three 
building blocks and the relative proportions between them used during synthesis. 
To increase the reaction rate, urethane catalysts such as tertiary amines or compounds as 
organotin and/or elevated temperatures (60–90 °C) may be used. Dibutyltin dilaurate and 
stannous octoate prevail in the articles about biodegradable PUs. Stannous octoate is more 
often used as catalyst due to its lower cytotoxicity compared to dibutyltin dilaurate [35].  The 
structure of both of them is shown in Figure 4. 
 
a) 
H3C(H2C)9H2C
O
O
Sn
O CH2(CH2)9CH3
O
CH3
CH3
 
 
 
b) 
 
O
O
-
 
 
O
O
-
 
Sn
2+
 
Figure 4: Chemical structure of a) dibutyltin dilaurate and b) stannous octoate. 
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 Hard segments 2.3.1.
Hard segments are in PU structure represented by isocyanates and chain extenders. 
Traditional aromatic diisocyanates are replaced by linear ones to avoid toxic or carcinogenic 
degradation products. The structures of polyisocyanates used to synthesize biodegradable PU 
biomaterials are showed in Table 2. Important aliphatic isocyanates used are 1,4-
diisocyanatobutane (BDI), hexamethylene diisocyanate (HDI), dicyclohexylmethane 
diisocyanate (H12MDI). Lysine-derived polyisocyanates, including lysine methyl (or ethyl) 
ester diisocyanate (LDI) and lysine triisocyanate have been extensively investigated, as they 
did not show any harmful effects in vivo [36]. As published by Zhang et al. [37] in their tests 
on rabbit bone marrow stromal cells, LDI-glucose synthesized polymers induced no 
immunogenic reaction and no antibody responses in the host. Their PU did not cause any 
accumulation of macrophages (foreign body giant cells) or tissue necrosis around the material. 
 
Table 2: Isocyanates used in polyurethane chemistry for tissue engineering. 
Chemical name Structure 
1,4-Diisocyanatobutane (BDI) 
 
N C O
NCO
 
1,6-Diisocyanatehexane 
or hexamethylene diisocyanate (HDI) 
 
N C O
NCO
 
Dicyclohexylmethane diisocyanate 
(H12MDI) 
 
N C ONCO
 
Lysine methyl ester diisocyanate 
(LDI) 
 
NCO
OO
N C O
CH3
 
 
Reactions of isocyanate are summarized in Figure 5a-e. Water reacts with isocyanates to 
form carbamic acid which is an unstable compound and decomposes immediately to an amine 
and carbon dioxide gas. The water reaction is used to synthesize PU foams (called in tissue 
engineering scaffolds), where the carbon dioxide gas acts as a blowing agent. Isocyanates 
react with hydroxyl- and amino-functional molecules by addition to the carbon-nitrogen 
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double bond. Urethane bonds are formed by reaction of isocyanates with hydroxyl-functional 
molecules and urea linkages are formed by reaction with amines. The excess of isocyanate is 
used to introduce certain degree of crosslinking, which is desirable for improved mechanical 
strength, since it leads to the formation of allophanate and biuret branch points [34]. 
 
a)  With water: amine  
R N C O + H2O R NH2C OH
O
R N
H
+ CO2
 
 
 
b)  With alcohol: urethane 
 
R N C O OH R'+
R
NH
CO
O
R' 
 
 
c)  With amine: urea 
 
R N C O NH2 R'+ R
NH
CO
NH
R'  
 
 
d)  With urethane group: allophanate 
 
R N C O
R'
NH
CO
O
R''
+
R
NH
CO
N
R'
CO
O
R'' 
 
 
e)  With urea group: biuret 
 
R N C O + R'
NH
CO
NH
R'' R
NH
CO
N
R'
CO
NH
R'' 
 
 
Figure 5: Reactions of isocyanate with other functional groups. 
The relative fractions of the hard and soft segments affect the mechanical properties of 
segmented PUs. Hard segment content increases with increasing chain extender to polyol 
ratio. This yields harder and stiffer polymers with higher tear strength but lower elongation at 
break. Gisselfaelt et al. [38] demonstrated this in PUs made of MDI and 1,3-diaminopropane 
as hard segment part and PCL as a soft segment. Reducing the PCL soft segment molecular 
weight from 2000 to 530 g·mol-1 increased the hard segment content from 21.9 to 51.4 wt%, 
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resulting in increased stiffness (6 to 45 MPa) and decreased elongation at break (77 to 32 %). 
The polymer became harder and less elastic with increasing hard segment content.  
 Soft segments 2.3.2.
Polyols are viscous liquids with hydroxyl end groups and a polyether, polyester, 
polycarbonate, polydimethylsiloxane, or polybutadiene backbone. The majority of 
biodegradable PUs are based on polyester or polyether macrodiols. Typical representatives 
include polyethyleneglycol (PEG), polypropyleneglycol (PPG), polylactic acid (PLA), 
polyglycolic acid (PGA) and their copolymer polylactic-co-glycolic acid (PLGA), 
polycaprolactone (PCL) or polyhydroxybutyrate (PHB). Their properties and characterization 
have already been reviewed many times [39, 40]. Their major properties are listed in Table 3. 
Soft segments affect biostability in the PU materials. Polyester soft segments were found to 
be more susceptible to hydrolytic degradation and attack by microorganisms than polyethers 
[1]. 
2.3.2.1. Poly(ethylene glycol) 
Poly(ethylene glycol) (PEG), also known as poly(ethylene oxide), poly(oxyethylene) or 
polyoxirane, is a hydrophilic, non-ionic polymer. PEG is known for its biocompatibility and 
low toxicity and is soluble in water via hydrogen bonding interactions. It has been approved 
by the U.S. FDA for internal consumption [41]. It can make a surface highly resistant to 
biological fouling and can reduce protein adsorption and resistance to bacterial and animal 
cell adhesion. Most PEGs with molecular weight < 1000 g·mol-1 are removed from the body 
unaltered only dissolved in the body fluids [42]. It is also apparently not readily recognized by 
the immune system. Modifying proteins with PEG have been shown to reduce the 
immunogenicity and antigenicity of these proteins and to increase circulation times [43]. 
PEGs having molecular weight less than 1000 g·mol-1 are viscous, colorless liquids. Higher 
molecular weight PEGs are waxy, white solids. The melting point of the solid is proportional 
to molecular weight, approaching a plateau about 67 °C. The molecular weights commonly 
used in biomedical applications range from a few hundreds to 20 000 g·mol-1[42]. 
Block copolymer of poly(ethylene-propylene-ethylene glycol) is sold under the trademark 
Pluronic®[45] and is often used in synthesis of bioresorbable  PUs. Gorna and Gogolewski 
[46] synthesized linear biodegradable polyurethanes with varying ratios of the hydrophilic-to-
hydrophobic segment. The hydrophilic segment was based on Pluronic® and the hydrophobic 
segment was based on PCL diol. The polymers absorbed up 3.9 % of water depending on the 
chemical composition. Tensile strength, Young's modulus and elongation at break of the 
polymers were in the range of 11–46 MPa, 4.5–91 MPa and 370–960 %. Degradation in vitro 
caused 2 % of mass loss in 48 weeks. The extent of degradation was dependent on the 
polymer composition and the hydrophilic segment content. 
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Table 3: Physical properties of the biodegradable polymers used as polyols in formation of polyurethane.  
Synthetic polymer Thermal and mechanical properties Degradation properties Applications Ref. 
 Tm (°C) Tg (°C) 
Elastic 
modulus (GPa) 
Time 
(months) 
Products   
PEG - 
Upper limit 
at 67 °C 
- Immediately 
Dissolves in body 
fluids 
Laxatives, bowel preparation 
before surgery, carrier for active 
ingredients  
42 
PCL 58-63 -60 0.4 >24 Caproic acid 
Sutures, dental orthopaedic 
implants 
47 
PGA 225-230 35-40 5-7 3-4 Glycolic acid 
Suture anchors, meniscus repair, 
medical devices, drug delivery 
50 
PLA 170 56 8.5 12-18 L-lactic acid 
Fracture fixation, suture anchors, 
meniscus repair 
40, 50 
PLGA (50/50) Amorphous - 2.0 1-2 weeks 
D,L-lactic acid and 
glycolic acid 
- 43 
PLGA (85/15) Amorphous - 2.0 5-6 weeks 
D,L-lactic acid and 
glycolic acid 
Interference screws, suture 
anchors, ACL reconstruction 
43 
PHB 177 2 3.5 >17 
D-3-hydroxybutyric 
acid 
Screws 55, 57 
 18 
2.3.2.2. Poly(-caprolactone)  
Poly(-caprolactone) (PCL) is a semicrystalline, bioresorbable polymer belonging to the 
aliphatic polyesters. PCL has melting point ranging between 59 and 64 °C and a glass 
transition temperature of about −60 °C. PCL can be prepared either by ring-opening 
polymerization of -caprolactone using a variety of anionic, cationic and co-ordination 
catalysts or via free radical ring-opening polymerization of 2-methylene-1-3-dioxepane [47]. 
It is regarded as a soft and hard tissue compatible bioresorbable material and has been used in 
biomedicine e.g. as a scaffold, sutures or fixation devices [48]. 
The PCL homopolymer has a total degradation of 2–4 years depending of the starting 
molecular weight used for the implant. Its degradation pathway undergoes a two-stage 
degradation process. First, the non-enzymatic hydrolytic cleavage of ester groups, and second, 
when the polymer has lower molecular weight (less than 3000) it undergoes intracellular 
degradation as evidenced by observation of PCL fragments uptake in phagosomes of 
macrophages and giant cells and within fibroblasts [47]. Local decrease of pH during the first 
stage has been observed same as in other polyesters. The combination of PCL with other 
materials such as bioceramics can suppress the local decrease of pH during degradation [49]. 
2.3.2.3. Polyglycolic acid 
Polyglycolic acid (PGA) is a semicrystalline biodegradable polymer known to lose its 
strength in 1–2 months when hydrolyzed and losses mass within 6–12 months. PGA sutures 
(Dexon®) have been commercially available since 1970 [50]. The hydrolytic degradation in 
vivo may take place via nonspecific enzymes such as esterases and carboxyl peptidases that 
produce glycolic acid monomers. Glycolic acid monomers are then converted enzymatically 
either into glycine, which can be used in protein synthesis, or into pyruvate, that enters the 
tricarboxylic acid cycle and yielding energy, CO2 and water [51]. Glycolic acid is partially 
excreted in urine. Hydrolysis is affected by the initial molecular weight, surface area/weight 
ratio, porosity and monomer concentration, geometric isomerism, conformation and 
crystallinity. Increased pH accelerates PGA degradation. 
2.3.2.4. Polylactic acid (PLA) 
Polylactic acid (PLA) is a thermoplastic, high strength, high modulus polymer, which 
belongs to the family of aliphatic polyesters. Poly(L-lactide) is a crystalline polymer 
(approximately of 37 % crystallinity) while poly(D,L-lactide) is amorphous. Poly(L-lactide) 
has a glass transition temperature between 60–65 °C and a melting temperature approximately 
of 175 °C, while poly(D,L-lactide) has glass transition temperature between 44–55 °C [40]. 
PLA undergoes scission of chains in the host body to monomeric units of lactic acid, which is 
a natural intermediate in carbohydrate metabolism. These characteristics make this polymer 
suitable for use as resorbable sutures, carries for the controlled release of drugs, implants for 
 19 
orthopaedic surgery or blood vessels, which finally can be replaced by living tissues. The 
attraction of PLA as a biodegradable material is its ready availability from renewable 
resources such as corn starch (in the U. S.) and sugarcanes (rest of world). The PLA life cycle 
starts with corn starch. The plants are first milled to separate the starch, which is converted to 
lactic acid utilizing fermentation and a series of purification steps. It is fully compostable. It 
can be converted back to monomer and oligomer by enzymatic degradation, or it can be 
degraded into water, carbon dioxide and organic materials [52]. 
2.3.2.5. Poly(lactic-co-glycolic acid) 
Poly (lactic-co-glycolic acid) (PLGA) copolymer is built from the units of poly(lactic acid) 
and poly(glycolic acid). The rate of polymer degradation may affect many cellular processes, 
including cell growth, tissue regeneration, and host response. PLGA has been shown to 
undergo bulk erosion through hydrolysis of the ester bonds and the rate of degradation 
depends on a variety of parameters including the PLA/PGA ratio, molecular weight, and the 
shape and structure of the matrix. The degradation products are endogenous compounds 
(lactic and glycolic acid) and are nontoxic. The rate of degradation can be controlled by the 
ratio of PLA and PGA. The higher the content of glycolide units the faster is the degradation 
[53]. PLGA has good cell adhesion and proliferation. Various studies have been performed so 
far using micro- and nano-fabrication techniques to form three-dimensional scaffolds based 
on PLGA [43]. Another application of biodegradable PLGA is for use in guided tissue 
regeneration by providing a permeable material for space preservation or in drug delivery 
systems [54]. 
2.3.2.6. Polyhydroxybutyrate 
Poly-3-hydroxybutyrate (PHB) belongs to a group of polyesters called 
polyhydroxyalkanoates (PHAs). PHAs are biodegradable plastics produced by 
microorganisms. They have mechanical properties similar to some common synthetic 
thermoplastics and are environmentally degradable, where the products of decomposition are 
CO2 and H2O [55]. PHB has mechanical properties quite similar to commercial polypropylene 
with Young’s modulus 3.5 GPa, tensile strength of 40 MPa and melting point at 179 °C. 
Moreover, product of PHB degradation (3-hydroxybutyric acid) belongs to short-chain fatty 
acids and reveals antibacterial activity [56]. 
2.4. Biodegradation of polyurethanes 
PUs were firstly used as a biostable materials in medicine and since that time have been 
applied in a range of medical devices [58, 59] In late 1980s a failure on functions in the 
applications such as the pacemaker leads and breast implant coatings containing PUs was 
found [3]. Aromatic diisocyanates (e.g. methylene diphenyl diisocyanate (MDI) and toluene 
diisocyanate) have been recognized as potentially carcinogenic by-products of degradation. 
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To solve this problem, aliphatic diisocyanates such as 1,4-diisocyanatobutane (butyl 
diisocyanate, BDI) and lysine diisocyanates (LDI) started to be used instead of aromatic ones. 
These polymers exhibit better blood and tissue compatibility both, in vitro and in vivo tests, in 
comparison to materials where aromatic reactants were used [39]. 
PU elastomers with hydrophilic soft segments have been reported to exhibit increased 
water uptake, which has also been suggested to increase the degradation rate [38]. Mechanism 
of hydrolytic degradation that has been suggested by Hafeman et. al [63] is shown in Figure 6. 
Above mentioned phenomenons can be used to design PU materials with targeted physical 
properties. 
 
Figure 6: Schematic showing hypothesized mechanisms of PU scaffold degradation and 
soluble breakdown products. (A) Hydrolysis of ester bonds to yield -hydroxy acids (dotted 
line). (B) Abstraction of the -hydrogen atom in the R group adjacent to the urethane bonds 
by reaction with hydroxyl radicals to yield lysine or ethanolamine and carbon dioxide. (C) 
Abstraction of the -hydrogen atom in lysine by reaction with hydroxyl radicals to yield 
multiple degradation products, including NH4, -ketoacids, oximes, CO2, and carboxylic 
acids (degradation products not shown to simplify the diagram) [63]. 
The stability of segmented (block) PUs in the body depends not only on the composition 
and structure. It also depends on the presence of stabilizing additives, the chosen implant site 
and the sample’s purity and processing history. Fabrication technique, handling, residual 
solvent, sterilization method and device design are also important factors [23]. The common 
degradation pathway of poly(ester urethanes) is the hydrolysis of ester linkages. Through this 
way the degradation products are hydroxy acids as well as urethane and urea fragments with 
terminal acid groups. The hydrolysis of urethane and urea linkages to amine has been also 
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reported [60]. Hydrolysis of ester bonds is taking control of the degradation rate. The 
formation of acidic degradation products is known to autocatalyze polymer degradation and 
may cause in vivo inflammation [60]. 
By incorporating a chain extender that is recognizable by an enzyme, PU elastomers with 
degradable hard segments have been also synthesized [61]. Guan et al. [62] synthesized PUs 
from BDI, PCL-PEG-PCL macrodiol triblock copolymers and the peptide Alanine-Alanine-
Lysine (AAL) as a chain extender. The hard segment of this polymer was designed to be 
enzymatically degradable. Polymers synthesized from the AAL chain extender degraded 
faster than those synthesized from tetramethylenediamine (putrescin®) chain extender and the 
degradation products were observed to be non-cytotoxic. Further, materials synthesized from 
the AAL chain extender displayed mechanical properties comparable to those synthesized 
from usually used chain extender putrescin®. Obtained tensile strengths ranged from 15 to 
28 MPa, breaking strains 670–890 %. 
2.5. Polyurethane scaffolds 
Many techniques/methods are employed to process biomaterials into scaffolds. The reason 
why to make scaffolds rather porous than solid, is that cell colonization, in-growth and 
proliferation can proceed easier. Porosity leads to a weaker structure and it can also accelerate 
degradation due to the larger surface area. Having a porous structure allows nutrients to flow 
into the cells in the inner regions of the scaffold and for waste to be removed. The ideal pore 
size and pore morphology of the scaffold depends on the intended purpose of the scaffold. It 
has been claimed that the optimal pore size is between five and ten times the diameter of the 
cell i.e. 100–300 μm [65]. 
Techniques used for processing of scaffolds have been reviewed many times [65, 66]. 
Because the dissertation thesis is not directly focused on preparation of scaffold, there is just a 
list of them. Techniques involve solvent casting and particulate leaching, gas foaming, non-
woven fibers, fiber knitting and phase separation/emulsion freeze drying. Emerging 
fabrication techniques under development include solid free forming techniques, including 3D 
printing and fused deposition. Characteristics differentiating the techniques are the use of 
solvents, heat, pressure, or pore creating agents. 
The scaffold should be non-immunogenic, non-toxic, biocompatible, biodegradable and 
easily manufactured. The cells survival and growth is affected by macro and micro-structural 
properties. Scaffold should possess an interconnected and spread porosity (usually exceeding 
90 %) with a highly porous surface and microstructure. This would allow in vitro cell 
adhesion and would provide the necessary space for neovascularization in vivo. Pore 
interconnectivity directly influences the diffusion of physiological nutrients and gases to cells 
as well as the removal of metabolic waste and by-products from cells. 
 22 
Grenier et al. [67] examined two medical grade polyurethanes for their potential use as 
scaffold for vascular tissue engineering applications. Those two polyurethanes were 
commercially available Bionate 55D (polycarbonate-urethane – thermoplastic elastomer 
formed from hydroxyl terminated polycarbonate, an aromatic diisocyanate, and a low 
molecular weight glycol as a chain extender [68]) and Elasthane 75D (polyether-urethane – 
made of poly(tetramethylene oxide) and an aromatic diisocyanate and a low molecular weight 
glycol chain extender [68]). Scaffolds were prepared via pressure differential/particulate 
leaching technique, which improved the pore interconnectivity of the scaffolds. Two types of 
porogen were used for fabrication of the scaffolds, NH4Cl particles, and paraffin spheres. In 
the preparation procedure, they firstly dissolve the polyurethane in dimethylformamide. Then 
the cylindrical mold was filled with porogen and using the pressure dissolved polymer was 
pushed into the mold.  After a certain time the mold was removed from the apparatus and 
placed in a fume hood at ambient temperature for 2 days to evaporate the solvent. The 
polymer matrix was then pushed out of the mold and immersed in deionized water for NH4Cl 
particles or hexane for paraffin spheres, to leach out the porogen. 
Sharifpoor et al. [69] synthesized degradable polar hydrophobic ionic polyurethane (D-
PHI) porous scaffold. D-PHI scaffold properties were adjusted through the introduction of a 
lysine-based cross-linker. Increasing lysine-based cross-linker concentration resulted in an 
increase of the elastic modulus (from 0.5 to 21 MPa), a decrease of the elongation-at-yield 
(from 45 to 5 %) and a reduction of scaffold swelling (from 170 to 100 %). Based on a 
preliminary study with vascular smooth muscle cells, D-PHI scaffolds demonstrated the 
ability to support cell adhesion and growth during 2 weeks of culture, suggesting their 
potential suitability for longer term vascular tissue engineering. The versatility of the D-PHI 
properties may allow for the tailoring of cell-material interaction and ultimately functional 
tissue regeneration. 
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2.6. Injectable polyurethanes 
Synthetic polymer systems as injectable liquids, gels or pastes have the advantage for the 
surgical operations, because they minimalize the invasive procedures. The way how to deliver 
the gel to the proper place in the body is for example arthroscopic delivery. Injectable 
polymer systems could help in complex fracture and bone defect repair, where substantial 
amount of bone is lost due to trauma or disease. Further, they can be used to stabilize and 
reinforce the fixation of implants such as plates and screws, particularly in patients with 
osteoporotic bone [70]. Several biodegradable injectable hydrogel systems made of 
polyurethanes have been suggested as described below. 
Thermoresponsive polymers showing enhanced rheological properties were published by 
Cohn et al. [71]. PUs were synthesized from PEO-PPO-PEO triblock macrodiols end capped 
with lactid acid or -caprolactone oligoesters and chain extended with HDI. The length and 
composition of the ester blocks affected the viscosity response with temperature. Gels with 
viscosities up to 193 kPa∙s were prepared. Degradation times ranging from days to months 
were achieved by varying the composition of the backbone. The improved rheological 
properties of these materials were suggested as potential injectable drug delivery system. 
Guelcher et al. [72] introduced two-component injectable polyurethane hydrogels as useful 
biodegradable material for fracture healing. PU network consisted of reactive liquid molding 
low-viscosity prepolymers derived from lysine polyisocyanates and poly(caprolactone-co-
D,L-lactide-co-glycolide) triols. The values of Young’s modulus ranged from 1.20 
to 1.43 GPa, and the compressive yield strength varied from 82 to 111 MPa, which is 
comparable to the strength of poly(methyl methacrylate) bone cements. They studied the 
biodegradation in vitro, where the materials decomposed to non-cytotoxic products. As well, 
the material supported the attachment and proliferation of human osteoblasts. 
An injectable, two component LDI-based polyurethane system with commercial name 
PolyNovo® [73] was developed for orthopaedic applications with curing in situ. This self-
setting system can be inserted to the body arthroscopically in liquid form. It polymerizes at 
physiological temperature in situ to provide appropriate bonding strength and mechanical 
support comparable to or superior to widely used bone cements. This material has also been 
shown to promote favorable cell adhesion and proliferation [74]. 
Although quite a lot of articles dealing with injectable PU concept have been published, 
the injectable PUs have still basic problems that should be overcome. The first one is the 
toxicity and ultimate fate of reactive components that are not incorporated in the final cured 
product [75]. The nature of the reaction or reactivity of the NCO-terminated prepolymer is 
exothermic, which may destroy the surrounding tissue. And finally, diffusion of water from 
the wound bed into reactive PU can result in over-expansion of the formed scaffold or in 
forming large voids in the scaffold. 
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2.7. Polyurethanes modified by biologically active substances 
Each group, either natural or synthetic polymers, has its advantages and disadvantages for 
the use in tissue engineering. Synthetic polymer-derived materials lack cell recognition 
signals and the surfaces are hydrophobic, which affect the seeding of cells. Naturally derived 
polymers such as collagen have the advantage of good cell interaction and hydrophilicity, but 
generally lack adequate mechanical properties and batch-to-batch consistency [76]. To 
overcome the drawback of the synthetic materials, naturally occurring polymers have been 
used to modify the synthetic materials. Polyurethanes have been used for a long time as 
potential candidates in various fields of biomedicine. Thus, different natural polymers were 
already used for their modification, such as collagen [77, 78], elastin, [79-82], hyaluronic acid 
[83-86], silk fibroin [87, 88], chitosan [89-91], bioactive glasses [92-94] or nanocellulose. 
The last mentioned natural polymer was used in the presented work in the form of cellulose 
nanocrystals, and therefore is reviewed more into detail in the following section. 
 Nanocellulose - general properties 2.7.1.
As natural nanoscaled material, nanocellulose provides unique properties different from 
other nanomaterials, including special morphology and geometrical dimensions, crystallinity, 
liquid crystalline behavior, alignment and orientation, mechanical reinforcement, 
biocompatibility, biodegradability and lack of toxicity [95]. Nanocellulose can be divided into 
three different types such as cellulose nanocrystals (CNC), cellulose nanofibrils (CNF) and 
bacterial cellulose (BC) also called microbial cellulose [96]. 
Cellulose nanocrystals with other designations such as nanocrystalline cellulose, cellulose 
(nano) whiskers or rod-like cellulose microcrystals are nanoparticles with diameter in a range 
of 5–30 nm, and length between 100–500 nm derived from plant cellulose, or length of 100 
nm to several micrometers from tunicate and algae celluloses. Acid hydrolysis is commonly 
performed for the extraction of CNC through the removal of amorphous regions and 
preservation of highly-crystalline structure. Scheme of their structure is shown in Figure 7. 
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Figure 7: Schematics of (a) single cellulose chain repeat unit, showing the directionality of 
the 1 -> 4 linkage and intrachain hydrogen bonding (dotted line), (b) idealized cellulose 
microfibril showing one of the suggested configurations of the crystalline and amorphous 
regions, and (c) cellulose nanocrystals after acid hydrolysis dissolved the disordered regions. 
Figure depicted according to [97]. 
Different from rigid CNC, cellulose nanofibrils (CNF) consist of both individual and 
aggregated nanofibrils made of alternating crystalline and amorphous cellulose domains, 
which attributes to the morphology of CNF with soft and long chains. Due to the 
entanglement of long cellulosic chains, it is not so easy to determine the length of CNF with 
microscopic techniques. Therefore, only the information of fibril width for CNF is provided 
in the studies, which varies from 10 to 100 nm depending on the source of cellulose, 
defibrillation process and pretreatment. Regarding the preparation of CNF, mechanically 
induced destruction processes are mainly applied, which involves high-pressure 
homogenization and grinding before or after chemical or enzymatic treatment. Multiple 
mechanical shearing effectively delaminate individual microfibrils from cellulosic fibers. 
Contrary to CNC and CNF, bacterial cellulose (BC) is produced by biosynthesis typically 
by bacteria such as Acetobacter xylinum [98]. The major advantage is that the product is in a 
pure form and doesn’t require removing of unwanted impurities or contaminants such as 
lignin, pectin and hemicellulose. During the biosynthesis of BC, the glucose chains are 
produced inside the bacterial body and extruded out through pores present on the cell 
envelope. With the combination of glucose chains, microfibrils are formed and further 
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aggregate as ribbons (nanofibers). These ribbons subsequently generate a web-shaped 
network structure with cellulosic fibers (BC), which has a diameter of 20–100 nm with 
different types of nanofiber networks. 
 Preparation of CNC 2.7.2.
Considerable academic and industrial research effort have been devoted to developing 
cellulose nanocrystals and nanofibers. The reasons for this are e.g. that cellulose is one of the 
most abundant polymeric material in nature, is available everywhere, can be obtained from 
different resources, is biodegradable and can be modified to generate whiskers of high aspect 
ratio, high modulus and low density [99]. To obtain these nanofibers, cellulose must be 
separated from other components of the plant and exposed to different treatments that 
decompose its hierarchical structure down to nanoparticles. One frequently reported method is 
the acidic hydrolysis of cellulose, which produces cellulose nanocrystals with diameter of 5–
20 nm and length ranging from 100 nm to approximately 500 nm, depending on the cellulose 
source and the preparation process [100, 101] Although the high OH concentration on the 
surface of the crystals suggests high attraction between them, the use of sulfuric acid during 
hydrolysis is known to leave sulfate groups on the crystal surface, which produce repulsion 
and help to produce stable suspensions in aqueous media and highly polar solvents [102]. 
The surface hydroxyl groups on the cellulose can be reacted to produce surface-modified 
cellulose crystals [101]. Coreaction with a polymerizable mixture has also been reported, so 
that the nanofibers became covalently attached to the polymer [102]. 
 Nanocellulose-polyurethane composites 2.7.3.
A couple of systems suggesting PU-CNC composites have been introduced in the 
literature. Those are usually using CNC dispersed in N,N-dimethylformamide (DMF) and PU 
matrix dispersed in the same solvent. PU nanocomposite films are then prepared by casting 
the mixture of those two components into the mold and after removing the solvent the films 
are obtained with thickness ranging from 0.1 mm to 0.5 mm. 
Pei et al. [18] observed a strong reinforcement effect by adding CNC into PU matrix made 
of 4,4’-diphenylmethane diisocyanate (MDI) and 1.4-butanediol as hard segment and 
poly(tetramethylene glycol) as soft segment. CNC were grafted by MDI before the synthesis 
proceeded. With only 1 wt.% of cellulose nanocrystals incorporated, an 8-fold increase in 
tensile strength and 1.3-fold increase in strain-to-failure were achieved. It is unusual to 
improve the modulus while at the same time significantly improve the strength and toughness. 
Such enhancement of mechanical properties was explained by CNC reinforcement in the hard 
domains and also by increased effective cross-link density of the elastomer network due to 
CNC-PU molecular interaction. Preferential reinforcement of CNC in the hard microdomains 
rather than in the soft segments of PU avoided the undesired stiffening of the soft domain and 
maintained the large strain-to-failure. 
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The similar strategy with different PU system performed Rueda et al. [19]. The surface of 
CNC was grafted by hexamethylene diisocyanate (HDI) and the PU nanocomposite was 
processed via similar solvent casting procedure as Pei et al. Successful grafting was 
confirmed by solid state NMR and it was claimed that half of the C6-OH groups in glucose 
units were grafted by HDI. Comparison between nanocomposite material with unmodified 
CNC and HDI modified CNC, both in 1.5 wt %, showed more tough material when used 
unmodified CNC without impeding the extension of the soft segment and provoked a 
positively impact on the mechanical properties. The use of HDI modified CNC resulted in 
preferential interaction of HDI anchored chains with hard segment which provided fairly good 
Young’s modulus however showed decrease to more than half of values in ductility and strain 
at break. The same group published later the cell evaluation tests of those PU nanocomposites 
[103]. Cells seeded on top of the materials showed that L-929 fibroblasts colonized the 
materials surface giving rise to good substrates for cell adhesion and proliferation. 
Saralegi et al. [104] used renewable resources, such as castor oil based highly crystalline 
polyol and corn-sugar based chain extender. CNC PU nanocomposites were prepared where 
PU matrix was partially crystalline. They observed increase in Young’s modulus and yield 
strength by increasing CNC content and at the same time decrease in strain at break and 
tensile strength. Such behavior of the material was explained by CNCs influencing the 
mobility of amorphous segments. However due to high crystalline nature of both soft and 
hard segments, that also served as reinforcing agents, the effect of the addition of CNC on the 
final properties was less pronounced. 
 Nanocellulose in medicine 2.7.4.
One of the targeting outcomes of that dissertation work is utilizing the materials for further 
use in medicine. Nanocellulose as a unique natural material has gained much attention for its 
use in medicine. The studies of blood vessel replacement are the most developed reaching the 
stage of clinical research as various systems have been already tested on animals [105]. 
Regarding other studies on nanocellulose e.g. for soft tissue replacement and regeneration, 
most reports are still in the fundamental stage, and mainly focus on the comparison of 
different properties between nanocellulose-based materials and real organs. Due to the most 
developed section of vessel replacement studies some of them are described more into detail 
below. 
One of the most common treatments of cardiovascular disease is the graft surgery, which is 
performed to supply blood to the damaged tissue (e.g. heart) with a suitable blood vessel 
replacement. Biosynthesized BC has already been processed by researchers to form artificial 
vascular substitutes. The team of Dieter Klemm (University Jena and Polymer Jena, 
Germany) was the first research organization to investigate and apply artificial vascular 
substitute obtained from BC. They have evolved a clinical product named BActerial 
SYnthesized Cellulose (BASYC
®
) with high mechanical strength in wet state, enormous 
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water retention property and low roughness of inner tube surface [105]. In comparison with 
conventional synthetic vascular graft materials, e.g. polyester (Dacron
®
) or ePTFE, 
biosynthetic BC tubes can be suitable for small diameter (<4 mm) vascular conduits. It has 
been reported that BASYC from BC has been successfully used as the artificial blood vessel 
in rats and pigs for microsurgery [106]. 
Different from BC biosynthetic procedure, it is impossible to directly fabricate the tubes 
from CNC and CNF. Therefore, the development of CNC or CNF-based blood vessel 
replacement commonly includes the use of a matrix material. Novel biomaterials from 
polyurethane reinforced with CNF have been reported to be potentially used as vascular 
replacement [107]. The presence of CNF in polyurethane improved the elastic properties of 
the material, coupled with low thrombogenicity and improved physical and mechanical 
properties. CNF/polyurethane biomaterials, with a wall thickness of 0.7–1.0 mm, were 
applied as vascular prostheses between the brachiocephalic trunk and the right common 
carotid artery in a 26-year-old male patient with multiple endocrine neoplasia. No further 
effect of this CNF/polyurethane biomaterial in clinical study was reported yet. 
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3. MAIN AIMS 
The dissertation thesis is focused on synthesis of biodegradable polyurethane elastomers 
and their modification by biologically active cellulose nanocrystals. Firstly, the PU material 
was synthesized with tailorable mechanical and biodegradable properties. For preparation of 
PU elastomers were chosen hydrophilic poly(ethylene glycol) and hydrophobic 
poly(caprolactone) as diols, aliphatic hexamethylene diisocyanate as hard segment and 
stannous octoate as catalyst. Characterization of synthesized materials was evaluated from the 
viewpoint of changing the diol ratios (hydrophilic vs. hydrophobic nature) and changing the 
crosslink density (ratio between NCO/OH groups). Both parameters possess ability to tailor 
the physico-chemical properties for potential application in medicine. 
Further modification by cellulose nanocrystals (CNCs) was performed to study the 
nanofiller influence on material behavior and also for possible improvement of the 
biocompatibility. CNCs were used either untreated or surface modified by polyethylene 
glycol. 
 
Proposed dissertation thesis can be summarized in following highlights: 
 solvent free synthesis of biodegradable PU material 
 interpretation of PU behavior with different PEG/PCL ratio 
 tailoring the properties of material by changing crosslink density (NCO/OH ratio) 
 solvent free synthesis of PU nanocomposite 
 structural investigation of the nanocomposite’s behavior 
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4. EXPERIMENTAL PART 
4.1. Chemicals 
Text is not available in the public version. 
4.2. Solvent free synthesis of bio-PU 
Text is not available in the public version. 
4.3. Synthesis of bio-PU nanocomposites 
Text is not available in the public version. 
4.4. Characterization 
 UV-VIS 4.4.1.
Absorbance spectra were obtained on Jasco V-630 UV-VIS spectrophotometer in the range 
of wavelengths from 240 to 1100 nm with the resolution of 0.5 nm. 
 Attenuated total reflection infrared spectroscopy (ATR-IR) 4.4.2.
Attenuated total reflection infrared spectroscopy (ATR-IR) was conducted on Fourier-
transform infrared spectrometer (Bruker Tensor 27, USA) equipped with the germanium 
crystal for ATR over the spectral range from 4000 to 600 cm
-1
 at the resolution of 4 cm
-1
 and 
32 scans. 
 Thermogravimetric analysis (TGA) 4.4.3.
Thermal decompositions were investigated by performing TGA (TA Q500, USA) with 
sample mass in the range of 5–10 mg. All measurements were carried out in the nitrogen 
atmosphere with the nitrogen flow rate of 100 ml·min-1. Heating rate was set as 10 °C·min-1 
starting from 25 °C up to 750 °C. 
 Differential scanning calorimetry (DSC) 4.4.4.
The calorimetric measurement was carried out utilizing DSC (Netzsch 204 F1, Germany) 
in the nitrogen atmosphere. Each sample (5–10 mg) was cooled with the rate of 5 °C·min-1 
and heated with heating rate of 10 °C min-1. Raw data were processed using the NETZSCH 
Proteus
®
 Software to obtain glass transition temperature (Tg), melting temperature (Tm) and 
melting enthalpy (Hm). The crystallinity (c) was calculated from the first DSC heating run 
according to the following equation: 
                       c (%) = (∆𝐻𝑚 × 100)/(𝑤 × ∆𝐻𝑚
0 ) (1) 
where ∆𝐻𝑚 is heat of fusion of the bio-PU sample, ∆𝐻𝑚
0  is heat of fusion of 100 % crystalline 
PCL (135.44 J·g-1) [108] and w is the PCL’s weight fraction in the bio-PU sample. 
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 Wide-angle X-ray scattering (WAXS) 4.4.5.
Wide-angle X-ray scattering (WAXS) was performed on the diffractometer (Rigaku 
MiniFlex 600, Japan) with Cu K radiation beam ( = 1.5406 Å) operated at 40 kV and 15 
mA in the scattering angle (2 range from 5° to 35° using the scan rate of 2° min-1 with step 
of 0.02°. As a reference material, WAXS of a commercial PCL (Mn = 80 000 g mol
-1
) was 
also measured. 
 Swelling 4.4.6.
Swelling ratio of the 1 cm × 1 cm × 1 mm specimens cut out of the bio-PU films was 
measured in ultrapure water (UPW) at laboratory temperature. The samples weight was 
measured within the first hour every ten minutes, within the second hour every 20 minutes 
and then every hour for the next 4 hours, with the last measurement performed after 1 day 
since the beginning of the swelling experiment. Water uptake was calculated according to the 
formula (2): 
 Water uptake (%) = (𝑤𝑠 − 𝑤𝑑) 𝑤𝑑⁄ × 100 (2) 
where ws is the weight of swollen sample at the given time and wd is the weight of dry sample. 
Each sample was measured 3 times.  
 Hydrolytic degradation 4.4.7.
Hydrolytic degradation tests employing the swelled samples were carried out in an 
incubator at 37 °C in UPW for 365 days. Each measurement is an average of 3 specimens. 
The specimens were removed at the given time from vials with distilled water, wiped using 
filter paper and weighed to determine the weight loss. The UPW was changed every two 
weeks. Mass loss was calculated according to formula (3): 
 Mass loss (%) = (𝑤0 − 𝑤𝑡) 𝑤0⁄ × 100 (3) 
where w0 is the weight of swollen sample after 24 hours in water and wt is the weight of the 
sample in the given time. 
 Extraction 4.4.8.
Extractions were performed using Soxhlet apparatus. Small pieces of dry films (1×1 cm 
and 1 mm thick) were used for the extractions. The extractions were performed for 8 hours 
with volume 200 ml of solvent, extracted samples were dried in the vacuum oven to the 
constant weight. Extracts from acetone with dissolved residues were evaporated followed by 
drying in the vacuum oven to be evaluated by ATR-IR. Bio-PU films with NCO/OH ratio 1.2 
were extracted in acetone and in N,N-dimethylformamide (DMF). Both extractions either in 
acetone or DMF were carried out via the same procedure. 
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 Tensile measurement 4.4.9.
Tensile tests were performed employing the tensile tester (Zwick Roell Z010, Germany) 
according to the ISO 527 standard. Dog-bone specimens obtained according to ISO 527-2/5B 
were 35 mm in length, 2 mm in width in the middle part, 1 mm thick and gauge length was 
10 mm. The 500 N load cell was used for the measurement with the cross-head speed of 
10 mm·min-1 corresponding to the 100 %·min-1 deformation rate. The 0.1 N preload was used 
and all tensile measurements were performed at the laboratory temperature. Each sample was 
measured at least 5 times and data were averaged to get the standard deviation. 
 Dynamic light scattering 4.4.10.
Dynamic light scattering (DLS, DynaPro Nanostar, Wyatt) using digital autocorrelator and 
laser with wavelength of 658 nm was performed to qualitatively prove the size distribution of 
nanoparticles. DLS was measured from a dilute suspension of either CNC or CNC-PEG 
nanoparticles. 
 Dynamic mechanical analysis (DMA) 4.4.11.
Dynamic mechanical analysis (DMA) was measured on a TA Instruments Q800 in tension 
mode with frequency 1 Hz and the temperature scanning rate 3 °C·min-1. Samples with 
thickness of 1 mm were cut to stripes with dimensions of 4 mm width and 15 mm length. 
 Transmision electron microscopy (TEM) 4.4.12.
Transmission electron microscopy (TEM) was carried out using Tecnai G2 Spirit Twin 12 
microscope (FEI, Czech Republic) Thin sections (∼60 nm) were cut at –80 °C by an 
ultramicrotome (Ultracut UCT, Leica, Germany) under cryogenic conditions (the sample and 
the knife temperatures were –85 °C and –50 °C, respectively). The ultrathin sections were 
transferred to a microscopic grid and observed in the bright field mode at the acceleration 
voltage of 120 kV. 
 Cytotoxicity evaluation 4.4.13.
Chosen samples were tested on cytotoxicity by seeding mesenchymal stem cells (MSCs) 
on bio-PU films and evaluation of spreading and proliferation after 24, 72  and 168 hours. 
Chosen bio-PU or PU nanocomposite films with a diameter of 6 mm and a thickness of 
1 mm were sterilized using combination of UV for 15 min and ethanol. Before seeding with 
MSCs, the films were incubated in culture medium (Dulbecco's Modified Eagle's medium 
with L-glutamine, 10% fetal bovine serum, 1% penicillin/streptomycin) overnight at 37 °C. 
Cells were seeded on PU films at a density of 3·104 cells·cm-2 in 48-well plate. PU films with 
seeded MSCs were cultivated at 37 °C and 5% CO2 atmosphere and cell viability was 
acquired in 24, 72  and 168 hours after seeding. The medium was changed every 3 days. 
Fluorescence microscopy and live/dead staining (calcein-AM/ propidium iodide) were used to 
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determine the cell viabillity. The mix of calcein-AM (2 μM) and propidium (1,5 μM) in 
phosphate buffered saline (PBS) was added to films containing seeded cells and incubated for 
15 min at 37 °C and 5% CO2 for live/dead cell detection. The cells were visualized using a 
Zeiss Axio Imager 2 microscope. 
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5. RESULTS AND DISCUSSION 
Text is not available in the public version. 
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6. CONCLUSIONS 
New solvent free method was successfully used for the synthesis of biodegradable 
polyurethanes (bio-PUs) and also for in situ synthesis of polyurethane nanocomposites filled 
by either unmodified or PEG grafted cellulose nanocrystals. 
Different diol ratios between PEG/PCL resulted in materials from brittle through elastic up 
to tough elastomeric films. The structural analysis revealed that crystalline PCL domains 
formed below the PEG/PCL weight ratio of 30/70 are responsible for abrupt increase in the 
elastic modulus, stress and deformation at break by order of magnitude. These domains 
reinforce the PU network and their small size allows for more uniform distribution of strain 
resulting in enhanced toughness. Extraction studies confirmed crosslinked structure of bio-
PUs although only bifunctional feedstocks were used. 
Variation between NCO/OH groups (isocyanate ratio) confirmed increase in crosslink 
density with increasing isocyanate ratio. Higher crosslink density reduced the ability of bio-
PUs to absorb water and followly prolonged the time of hydrolytic degradation. Systems with 
very low crosslinking tend to be weak and flexible, whereas polymers with high degrees of 
crosslinking were more rigid.  
Polyurethane nanocomposites filled by either unmodified or PEG grafted CNCs were 
successfully synthesized by evolved solvent free method. Presence of nanofiller promoted 
significant effect on stiffness explained by restricted motion of the rubbery PU matrix due to 
the presence of stiff and rod-like cellulose nanocrystals. 
Five representatives from all the samples were chosen for preliminary tests of human 
mesenchymal stem cells (MSCs) response to the material. MSCs didn’t adhere on PUs with 
high PEG content although the material was modified by low amount of biologically active 
CNCs. PUs with high abundance of PCL allowed cell adhesion on the surface, but promoted 
with timescale of one week detachment of the MSCs from the surface. 
Tailored biomaterials with adjustable functional properties are desirable for many 
applications ranging from drug delivery to regenerative medicine. Presented variation of PU 
materials possess great range of mechanical (toughness, flexibility) and physical (swelling, 
degradation) properties. Low adherence of cells to the bio-PU surface predestines the material 
for the use as an artificial vein. However for interaction with a body, further modification of 
the contact side is desirable by compounds favoring material attachment e.g. by RGD 
proteins. 
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8. LIST OF SHORTCUTS AND SYMBOLS 
c crystallinity 
AAL alanine-alanine-lysine 
AFM atomic force microscopy 
ATR-IR attenuated total reflectance infrared spectroscopy 
BASYC
®
 bacterial synthesized cellulose trademark 
BD 1,4-butanediol 
BC bacterial cellulose 
BDI tetramethylene diisocyanate or 1,4-diisocyanatobutane 
CT computed tomography 
CNC cellulose nanocrystals 
CNC-PEG cellulose nanocrystals grafted with poly(ethylene glycol) 
CNF cellulose nanofibrils 
DBTL dibutyltin dilaurate 
DMA dynamical mechanical analysis 
DMF N,N-Dimethylformamide 
D-PHI degradable polar hydrophobic ionic polyurethane  
DSC differential scanning calorimetry 
DVO divinyl oligomer  
B tensile strain at break or extensibility (%) 
ELP4 elastin-like polypeptide-4  
Ey Young's modulus (MPa) 
FTIR Fourier transform infrared spectroscopy 
GA glycolic acid 
H12MDI dicyclohexylmethane diisocyanate  
HA hydroxyapatite 
HA hyaluronic acid 
HDI hexamethylene diisocyanate or 1,6-diisocyanatehexane 
LA lactic acid 
LDI lysine diisocyanate 
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MDI Methylene diphenyl diisocyanate or 4,4'-methylene diphenyl diisocyanate 
NCO/OH isocyanate ratio or isocyanate index 
PCL polycaprolactone 
PCN poly(hexamethylene carbonate)  
PCU polycarbonate-urethane  
PEG polyethylene glycol 
PEO-PPO-PEO  polyethylene oxide-co-polypropylene oxide-co-polyethylene oxide 
PEU polyether-urethane  
PGA polyglycolic acid 
PHA polyhydroxyalkanoates 
PHB polyhydroxybutyrate 
PHV polyhydroxyvalerate 
PLA polylactic acid 
PLGA polylactic-co-glycolic acid 
PP polypropylene 
PU polyurethane 
Q water uptake (%) 
B  tensile stress at break or toughness (MPa) 
SBF simulated body fluids 
SEM scanning electron microscopy 
SMC smooth muscle cell 
TE tissue engineering 
TEDA triethylenediamine 
TGA thermogravimetric analysis 
U.S. FDA United States Food and Drug Administration 
WAXS Wide-angle X-ray scattering 
w/w weight/weight 
wt.% weight percent 
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9. APPENDIX 
Text is not available in the public version. 
 
10. LIST OF FIGURES 
Figure 1: General formation of polyurethane. 
Figure 2: Modelled primary structure of segmented polyurethane [20]. 
Figure 3: Hydrogen bonding between the chains of a polyurethane based on 1,6 – hexane 
diisocyanate and 1,4 – butane diol depicted according to [20]. 
Figure 4: Chemical structure of a) dibutyltin dilaurate and b) stannous octoate. 
Figure 5: Reactions of isocyanate with other functional groups. 
Figure 6: Schematic showing hypothesized mechanisms of PU scaffold degradation and 
soluble breakdown products. (A) Hydrolysis of ester bonds to yield -hydroxy 
acids (dotted line). (B) Abstraction of the -hydrogen atom in the R group 
adjacent to the urethane bonds by reaction with hydroxyl radicals to yield lysine 
or ethanolamine and carbon dioxide. (C) Abstraction of the -hydrogen atom in 
lysine by reaction with hydroxyl radicals to yield multiple degradation products, 
including NH4, -ketoacids, oximes, CO2, and carboxylic acids (degradation 
products not shown to simplify the diagram) [63]. 
Figure 7: Schematics of (a) single cellulose chain repeat unit, showing the directionality of 
the 1 -> 4 linkage and intrachain hydrogen bonding (dotted line), (b) idealized 
cellulose microfibril showing one of the suggested configurations of the 
crystalline and amorphous regions, and (c) cellulose nanocrystals after acid 
hydrolysis dissolved the disordered regions. Figure depicted according to [97]. 
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